5'-N-Ethylcarboxamidoadenosine (NECA), tritiated at the adenine-2,8 position. 5'-N-Ethylcarboxamidoadenosine is an adenosine analog that acts as an agonist at adenosine receptors A1, A2A, and A3.
For research use only. Not for use in diagnostic procedures
5'-N-Ethylcarboxamidoadenosine acts as an agonist at adenosine receptors, and is a vasodilator. Adenosine receptors are a group of GPCRs that play a role in blood flow.
We offer both agonist and antagonist radioligands for autoradiographic visualization or performing saturation and competition assays to determine receptor expression levels (Bmax), dissociation constants (Kd), association and dissociation rates (kon and koff), and inhibitor constants (Ki) for a variety of receptors. We develop our radioligands to the highest specific activity possible and provide high purity resulting in low non-specific binding products. Each of our ultra-pure radioligands is fully characterized for pharmacological action and validated in receptor binding assays.
Radiolabeled ligands remain the most sensitive method for probing receptor binding biology; yielding unprecedented sensitivity gives results that technicians and scientists can trust. For over 50 years, Revvity has been a leading supplier of New England Nuclear (NEN) radiochemicals, liquid scintillation cocktails, vials and nuclear counting detection instruments.
References for NET811:
Molecular Weight |
308.28
|
---|
Application |
Drug Discovery & Development
|
---|---|
Brand |
NEN Radiochemicals
|
Detection Method |
Radiometric
|
Label Position |
Specifically Labeled
|
One Unit Contains |
250.0 µCi
|
Radioisotope |
3H
|
Receptor Type |
Adenosine
|
Shipping Conditions |
Shipped in Dry Ice
|
Special Ordering Information |
This is a radioactive product - shipping address must have a license to receive radioactive materials.
|
Therapeutic Area |
Cardiovascular
CNS & Neurologic
Inflammation
Metabolic Disorders
|
Unit Size |
250 µCi
|
Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.
We are here to answer your questions.